Bharat Book

Choroidal Neovascularization - Pipeline Review, H2

Press Release   •   Dec 03, 2013 14:22 IST

Dec 03, 2013 : Bharat Book Bureau presents the new report, on 'Choroidal Neovascularization - Pipeline Review, H2 2013'  provides an overview of the indication’s therapeutic pipeline. It also reviews key players involved in the therapeutic development for Choroidal Neovascularization. Choroidal Neovascularization - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Choroidal Neovascularization.
- A review of the Choroidal Neovascularization products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Choroidal Neovascularization pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Choroidal Neovascularization.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Choroidal Neovascularization pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Lpath, Inc.
SANWA KAGAKU KENKYUSHO CO.,LTD.
Regeneron Pharmaceuticals, Inc.
Affitech A/S
MAT Biopharma
Promedior, Inc.
Resolvyx Pharmaceuticals, Inc

Table of contents :

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Choroidal Neovascularization Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Choroidal Neovascularization 8
Choroidal Neovascularization Therapeutics under Development by Companies 10
Choroidal Neovascularization Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Pre-Clinical Stage Products 15
Comparative Analysis 15
Choroidal Neovascularization Therapeutics - Products under Development by Companies 16
Choroidal Neovascularization Therapeutics - Products under Investigation by Universities/Institutes 17
Companies Involved in Choroidal Neovascularization Therapeutics Development 18
F. Hoffmann-La Roche Ltd. 18
Lpath, Inc. 19
SANWA KAGAKU KENKYUSHO CO.,LTD. 20
Regeneron Pharmaceuticals, Inc. 21
Affitech A/S 22
MAT Biopharma 23
Promedior, Inc. 24
Resolvyx Pharmaceuticals, Inc 25
Choroidal Neovascularization - Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Route of Administration 27
Assessment by Molecule Type 29
Drug Profiles 31
ranibizumab - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ranibizumab - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
iSONEP - Drug Profile 37
Product Description 37
Mechanism of Action 37

For more information kindly visit : http://www.bharatbook.com/Healthcare-market-research-reports/Choroidal-Neovascularization-Pipeline-Review-H2-20131.html

Related link : http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.